November 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 01, 2025
Projections indicate that, progressive pulmonary fibrosis (PPF) treatment industry is projected to rise from USD 0.6 billion in 2024 to USD 2.45 billion by 2034, reflecting a CAGR of 15.21% over the next decade. The Progressive Pulmonary Fibrosis (PPF) treatment market is growing because the prevalence of this condition is growing, likely due to a ...
November 01, 2025
According to market projections, the global NGS-based RNA-sequencing market, valued at USD 3.74 billion in 2024, is anticipated to reach USD 23.52 billion by 2034, growing at a CAGR of 20.1% over the next decade. The market is expanding due to its high accuracy in analyzing gene expression and detecting rare transcripts. Growing use in disease rese...
November 01, 2025
Based on market forecasts, the global miRNA tools and services market, projected at USD 417.69 million in 2024, is expected to reach USD 2399.94 million by 2034, growing at a CAGR of 19.34% over the forecast period.The miRNA tools and services market is growing due to rising focus on RNA-based therapy development. North America led the market due t...
November 01, 2025
Projections indicate that, the global GMP grade cytokines market will increase from USD 2.54 billion in 2024 to USD 6.48 billion by 2034, experiencing a CAGR of 9.84% over the next 10 years. The rising prevalence of chronic disorders and the burgeoning biotechnology sector drive the global market. North America led the global market owing to the ...
November 01, 2025
According to market projections, the spatial proteomics sector is expected to grow from USD 87.54 million in 2024 to USD 358.12 million by 2034, reflecting a CAGR of 15.14%. The spatial proteomics market is growing due to extensive research in drug discovery, disease mechanisms, and cell biology. North America leads the market due to a strong pre...
November 01, 2025
Projections indicate that, the global synthetic tissue engineering market will increase from USD 1.51 billion in 2024 to USD 5.61 billion by 2034, experiencing a CAGR of 14.14% over the next 10 years.The synthetic tissue engineering market is growing due to its promising novel class of biomaterials, which holds momentous potential for representin...
November 01, 2025
Research studies indicate that the in vivo CAR-T platform market is experiencing significant growth, driven by the rising demand for CAR-T cell therapies and ongoing technological advancements. North America leads the global market, supported by a strong presence of key industry players and a well-established research infrastructure....
November 01, 2025
According to market projections, the global immune repertoire sequencing market, valued at USD 337.43 million in 2024, is anticipated to reach USD 842.44 million by 2034, growing at a CAGR of 9.64% over the next decade. The increasing demand for a variety of therapies and the expansion of R&D are fueling the global market. North America led t...
November 01, 2025
According to market projections, the global high content screening market, valued at USD 1.52 billion in 2024, is anticipated to reach USD 3.12 billion by 2034, growing at a CAGR of 7.54% over the next decade.The growing new drug discovery research and the burgeoning molecular biology sector drive the market. The presence of key players and favor...
November 01, 2025
According to market projections, the CRISPR sector is expected to grow from USD 2.94 billion in 2024 to USD 8.58 billion by 2034, reflecting a CAGR of 11.24%. The market is growing due to rising demand for gene-editing therapies in genetic disorders and cancer treatment. Advancements in biotechnology and increased R&D investments are further ac...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com